The New Mexico DPA office opened in 2000. Since then, we have helped enact a range of drug policy reforms through the legislative process. Our focus areas include:
DPA's New Mexico State Director, Emily Kaltenbach, chairs the city of Santa Fe's Municipal Drug Strategy Task Force. In February 2020, the task force released a report that provides a roadmap for the city to move forward with drug strategies that focus on public health and safety.
"Santa Fe is another example of bold municipal leadership. The work of the Santa Fe Municipal Drug Strategy Task Force demonstrates how cities can step up and implement innovative drug policies rooted in science, compassion, and public health. Even when the federal government fails to act, cities can.” - Emily Kaltenbach
Sixty-nine percent (69%) of New Mexico residents support the legalization and regulation of marijuana for adults. DPA is working to end marijuana prohibition and protect the rights of medical marijuana patients in New Mexico. Join our Grow New Mexico campaign to legalize marijuana in the state.
DPA is committed to reducing the harms associated with drug use in New Mexico. Our priorities include expanding naloxone access, broadening 911 Good Samaritan Law immunity, increasing Medication Assisted Treatment (MAT) access, and establishing a Heroin Assisted Treatment (HAT) pilot program.
Drug arrests have led to unprecedented levels of incarceration in New Mexico, especially for people of color. DPA advocates for asset forfeiture reform, ending racial disparities in drug arrests, and decriminalizing drug possession and use.
(505) 983-3277 ph
nm "at" drugpolicy.org